| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bone sialoprotein binding | 1.25e-05 | 2 | 71 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | phospholipase A2 inhibitor activity | 1.24e-04 | 5 | 71 | 2 | GO:0019834 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 2.28e-04 | 84 | 71 | 4 | GO:0003684 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 3.37e-06 | 9 | 72 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 1.20e-05 | 2 | 72 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | TBC1D9B STON1 FGD1 PIP5K1A TBC1D22B NCK1 FGD5 IFT122 FGD3 CFAP46 DNAH1 | 1.95e-05 | 670 | 72 | 11 | GO:0120031 |
| GeneOntologyBiologicalProcess | endomembrane system organization | UBE2I NOMO2 COG7 ANXA2 ANXA2P2 ATL3 RAB1B EMD NOMO3 FER1L6 NOMO1 | 2.01e-05 | 672 | 72 | 11 | GO:0010256 |
| GeneOntologyBiologicalProcess | cell projection assembly | TBC1D9B STON1 FGD1 PIP5K1A TBC1D22B NCK1 FGD5 IFT122 FGD3 CFAP46 DNAH1 | 2.39e-05 | 685 | 72 | 11 | GO:0030031 |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 3.60e-05 | 3 | 72 | 2 | GO:1905602 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle receptor catabolic process | 3.60e-05 | 3 | 72 | 2 | GO:0032804 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle clearance | 7.18e-05 | 4 | 72 | 2 | GO:1905581 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor catabolic process | 7.18e-05 | 4 | 72 | 2 | GO:2000645 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular cholesterol transport | 7.18e-05 | 4 | 72 | 2 | GO:0032385 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular sterol transport | 7.18e-05 | 4 | 72 | 2 | GO:0032382 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane repair | 1.19e-04 | 5 | 72 | 2 | GO:1905686 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor binding | 1.19e-04 | 5 | 72 | 2 | GO:1905595 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular lipid transport | 1.19e-04 | 5 | 72 | 2 | GO:0032379 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 1.71e-04 | 31 | 72 | 3 | GO:0045048 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein receptor activity | 1.79e-04 | 6 | 72 | 2 | GO:1905599 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 2.50e-04 | 7 | 72 | 2 | GO:1900108 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor catabolic process | 2.50e-04 | 7 | 72 | 2 | GO:0032803 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle receptor catabolic process | 2.50e-04 | 7 | 72 | 2 | GO:0032802 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein receptor particle metabolic process | 2.50e-04 | 7 | 72 | 2 | GO:0032799 | |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis involved in cholesterol transport | 3.32e-04 | 8 | 72 | 2 | GO:1905600 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane repair | 3.32e-04 | 8 | 72 | 2 | GO:1905684 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor binding | 3.32e-04 | 8 | 72 | 2 | GO:1900122 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase I | 4.26e-04 | 9 | 72 | 2 | GO:0006362 | |
| GeneOntologyBiologicalProcess | regulation of nodal signaling pathway | 4.26e-04 | 9 | 72 | 2 | GO:1900107 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 4.56e-04 | 803 | 72 | 10 | GO:0030036 | |
| GeneOntologyBiologicalProcess | determination of left/right asymmetry in lateral mesoderm | 5.31e-04 | 10 | 72 | 2 | GO:0003140 | |
| GeneOntologyBiologicalProcess | transcription-coupled nucleotide-excision repair | 5.31e-04 | 10 | 72 | 2 | GO:0006283 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum organization | 5.37e-04 | 107 | 72 | 4 | GO:0007029 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis involved in cholesterol transport | 6.48e-04 | 11 | 72 | 2 | GO:0090118 | |
| GeneOntologyBiologicalProcess | protein insertion into membrane | 7.11e-04 | 50 | 72 | 3 | GO:0051205 | |
| GeneOntologyBiologicalProcess | positive regulation of lipoprotein particle clearance | 7.75e-04 | 12 | 72 | 2 | GO:0010986 | |
| GeneOntologyBiologicalProcess | regulation of intracellular sterol transport | 7.75e-04 | 12 | 72 | 2 | GO:0032380 | |
| GeneOntologyBiologicalProcess | regulation of intracellular cholesterol transport | 7.75e-04 | 12 | 72 | 2 | GO:0032383 | |
| GeneOntologyBiologicalProcess | UV protection | 9.14e-04 | 13 | 72 | 2 | GO:0009650 | |
| GeneOntologyBiologicalProcess | regulation of intracellular lipid transport | 9.14e-04 | 13 | 72 | 2 | GO:0032377 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 3.67e-06 | 9 | 75 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.57e-05 | 14 | 75 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 3.80e-05 | 3 | 75 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 3.80e-05 | 3 | 75 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | cell leading edge | 7.38e-05 | 500 | 75 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | carboxy-terminal domain protein kinase complex | 8.50e-05 | 24 | 75 | 3 | GO:0032806 | |
| GeneOntologyCellularComponent | ruffle | 9.74e-05 | 206 | 75 | 6 | GO:0001726 | |
| GeneOntologyCellularComponent | endoplasmic reticulum tubular network | 1.85e-04 | 31 | 75 | 3 | GO:0071782 | |
| GeneOntologyCellularComponent | signal peptidase complex | 1.89e-04 | 6 | 75 | 2 | GO:0005787 | |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 2.64e-04 | 7 | 75 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | pinosome | 6.84e-04 | 11 | 75 | 2 | GO:0044352 | |
| GeneOntologyCellularComponent | macropinosome | 6.84e-04 | 11 | 75 | 2 | GO:0044354 | |
| GeneOntologyCellularComponent | transcription factor TFIIH core complex | 8.19e-04 | 12 | 75 | 2 | GO:0000439 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 1.25e-03 | 59 | 75 | 3 | GO:0005637 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.29e-03 | 335 | 75 | 6 | GO:0061695 | |
| GeneOntologyCellularComponent | transcription factor TFIIH holo complex | 1.29e-03 | 15 | 75 | 2 | GO:0005675 | |
| GeneOntologyCellularComponent | lamellipodium | 1.43e-03 | 230 | 75 | 5 | GO:0030027 | |
| GeneOntologyCellularComponent | Schmidt-Lanterman incisure | 1.67e-03 | 17 | 75 | 2 | GO:0043220 | |
| GeneOntologyCellularComponent | transferase complex | 2.25e-03 | 963 | 75 | 10 | GO:1990234 | |
| GeneOntologyCellularComponent | serine-type endopeptidase complex | 2.31e-03 | 20 | 75 | 2 | GO:1905370 | |
| GeneOntologyCellularComponent | compact myelin | 2.55e-03 | 21 | 75 | 2 | GO:0043218 | |
| GeneOntologyCellularComponent | serine-type peptidase complex | 2.80e-03 | 22 | 75 | 2 | GO:1905286 | |
| GeneOntologyCellularComponent | protein kinase complex | 3.28e-03 | 170 | 75 | 4 | GO:1902911 | |
| GeneOntologyCellularComponent | nuclear periphery | 3.35e-03 | 171 | 75 | 4 | GO:0034399 | |
| Domain | LRRC37AB_C | 2.40e-10 | 4 | 75 | 4 | PF14914 | |
| Domain | LRRC37_N | 2.40e-10 | 4 | 75 | 4 | IPR032754 | |
| Domain | LRRC37AB_C | 2.40e-10 | 4 | 75 | 4 | IPR029423 | |
| Domain | LRRC37 | 2.40e-10 | 4 | 75 | 4 | PF15779 | |
| Domain | LRRC37A/B-like | 2.40e-10 | 4 | 75 | 4 | IPR015753 | |
| Domain | DUF2012 | 2.48e-07 | 4 | 75 | 3 | PF09430 | |
| Domain | DUF2012 | 2.48e-07 | 4 | 75 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 3.43e-06 | 8 | 75 | 3 | IPR013784 | |
| Domain | Peptidase_S26B | 1.59e-05 | 2 | 75 | 2 | IPR001733 | |
| Domain | TMPIT | 1.59e-05 | 2 | 75 | 2 | IPR012926 | |
| Domain | Pept_S26A_signal_pept_1_Ser-AS | 1.59e-05 | 2 | 75 | 2 | IPR019756 | |
| Domain | TMPIT | 1.59e-05 | 2 | 75 | 2 | PF07851 | |
| Domain | CarboxyPept_regulatory_dom | 1.73e-05 | 13 | 75 | 3 | IPR014766 | |
| Domain | - | 1.73e-05 | 13 | 75 | 3 | 2.60.40.1120 | |
| Domain | CarboxyPept-like_regulatory | 4.06e-05 | 17 | 75 | 3 | IPR008969 | |
| Domain | Pept_S26A_signal_pept_1_CS | 4.76e-05 | 3 | 75 | 2 | IPR019758 | |
| Domain | SPASE_I_3 | 9.50e-05 | 4 | 75 | 2 | PS00761 | |
| Domain | Peptidase_S24 | 9.50e-05 | 4 | 75 | 2 | PF00717 | |
| Domain | - | 9.50e-05 | 4 | 75 | 2 | 2.10.109.10 | |
| Domain | Peptidase_S24_S26A/B/C | 9.50e-05 | 4 | 75 | 2 | IPR015927 | |
| Domain | SPASE_I_1 | 9.50e-05 | 4 | 75 | 2 | PS00501 | |
| Domain | Peptidase_S24/S26_b-rbn | 9.50e-05 | 4 | 75 | 2 | IPR028360 | |
| Domain | Peptidase_S24_S26 | 9.50e-05 | 4 | 75 | 2 | IPR019759 | |
| Domain | FYVE | 2.11e-04 | 29 | 75 | 3 | PF01363 | |
| Domain | FYVE | 2.11e-04 | 29 | 75 | 3 | SM00064 | |
| Domain | Znf_FYVE-rel | 3.40e-04 | 34 | 75 | 3 | IPR017455 | |
| Domain | Znf_FYVE | 4.74e-04 | 38 | 75 | 3 | IPR000306 | |
| Domain | ZF_FYVE | 5.52e-04 | 40 | 75 | 3 | PS50178 | |
| Domain | Leu-rich_rpt_typical-subtyp | 7.30e-04 | 177 | 75 | 5 | IPR003591 | |
| Domain | LRR_TYP | 7.30e-04 | 177 | 75 | 5 | SM00369 | |
| Domain | LRR | 1.29e-03 | 201 | 75 | 5 | PS51450 | |
| Domain | LRR_1 | 1.88e-03 | 219 | 75 | 5 | PF00560 | |
| Domain | L_dom-like | 2.04e-03 | 328 | 75 | 6 | IPR032675 | |
| Domain | RhoGEF | 2.58e-03 | 68 | 75 | 3 | SM00325 | |
| Domain | RhoGEF | 2.81e-03 | 70 | 75 | 3 | PF00621 | |
| Domain | DH_2 | 2.81e-03 | 70 | 75 | 3 | PS50010 | |
| Domain | DH-domain | 2.92e-03 | 71 | 75 | 3 | IPR000219 | |
| Domain | - | 2.92e-03 | 71 | 75 | 3 | 1.20.900.10 | |
| Domain | Leu-rich_rpt | 4.68e-03 | 271 | 75 | 5 | IPR001611 | |
| Domain | LRR_8 | 4.98e-03 | 171 | 75 | 4 | PF13855 | |
| Domain | - | 5.03e-03 | 663 | 75 | 8 | 2.60.40.10 | |
| Domain | Ig-like_fold | 7.27e-03 | 706 | 75 | 8 | IPR013783 | |
| Pathway | REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA | 1.48e-04 | 5 | 55 | 2 | M27721 | |
| Pathway | REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA | 1.48e-04 | 5 | 55 | 2 | MM15463 | |
| Pathway | REACTOME_MRNA_CAPPING | 1.91e-04 | 29 | 55 | 3 | M745 | |
| Pathway | REACTOME_MRNA_CAPPING | 1.91e-04 | 29 | 55 | 3 | MM15409 | |
| Pathway | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS | 2.22e-04 | 6 | 55 | 2 | M27720 | |
| Pubmed | 4.38e-09 | 10 | 76 | 4 | 23064749 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.00e-08 | 3 | 76 | 3 | 25576386 | |
| Pubmed | Secretion of Annexin II via activation of insulin receptor and insulin-like growth factor receptor. | 4.00e-08 | 4 | 76 | 3 | 12431980 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 4.00e-08 | 4 | 76 | 3 | 31833031 | |
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 22419166 | ||
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 9267806 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ACADL NOMO2 ANXA2 ANXA2P2 SEC11A ATL3 PIP5K1A SEC11C NEIL3 RAB1B HADHB EMD ME2 NOMO3 NOMO1 KPNB1 | 7.89e-08 | 1451 | 76 | 16 | 30550785 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DDX19A ERCC2 SNW1 NOMO2 ANXA2 ANXA2P2 SEC11A HADHB EMD THOC2 DNA2 NOMO3 NOMO1 KPNB1 | 5.12e-07 | 1257 | 76 | 14 | 37317656 |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 5.57e-07 | 8 | 76 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 8.34e-07 | 9 | 76 | 3 | 36261522 | |
| Pubmed | 1.19e-06 | 10 | 76 | 3 | 8692841 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.63e-06 | 11 | 76 | 3 | 32820719 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX19A SNW1 ANXA2 SMCHD1 SEC11A FGD5 HADHB EMD GALNT5 THOC2 ME2 NOMO1 KPNB1 CHST13 | 2.24e-06 | 1425 | 76 | 14 | 30948266 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 3.32e-06 | 552 | 76 | 9 | 10737800 | |
| Pubmed | A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. | 4.71e-06 | 2 | 76 | 2 | 21486955 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16835333 | ||
| Pubmed | Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. | 4.71e-06 | 2 | 76 | 2 | 21737841 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19536308 | ||
| Pubmed | Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate. | 4.71e-06 | 2 | 76 | 2 | 23148505 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19580511 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 38290972 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 3013423 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35064931 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 8663148 | ||
| Pubmed | Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans. | 4.71e-06 | 2 | 76 | 2 | 28130864 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 36739096 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 8876669 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17549680 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22517898 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 39384746 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30462534 | ||
| Pubmed | G quadruplexes are genomewide targets of transcriptional helicases XPB and XPD. | 4.71e-06 | 2 | 76 | 2 | 24609361 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20826156 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23083890 | ||
| Pubmed | Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. | 4.71e-06 | 2 | 76 | 2 | 27468426 | |
| Pubmed | Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis. | 4.71e-06 | 2 | 76 | 2 | 38092984 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21572519 | ||
| Pubmed | Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. | 4.71e-06 | 2 | 76 | 2 | 19841537 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21788340 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27371724 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11335038 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27389701 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11278765 | ||
| Pubmed | Role of ERCC2 and ERCC3 gene polymorphisms in the development of osteosarcoma. | 4.71e-06 | 2 | 76 | 2 | 27051024 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31817350 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 37832154 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17360942 | ||
| Pubmed | Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. | 4.71e-06 | 2 | 76 | 2 | 19587120 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22234153 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30902828 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19022301 | ||
| Pubmed | Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis. | 4.71e-06 | 2 | 76 | 2 | 24742684 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 32687500 | ||
| Pubmed | Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. | 4.71e-06 | 2 | 76 | 2 | 22453828 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 38253182 | ||
| Pubmed | TMEM120A and B: Nuclear Envelope Transmembrane Proteins Important for Adipocyte Differentiation. | 4.71e-06 | 2 | 76 | 2 | 26024229 | |
| Pubmed | Agents that bind annexin A2 suppress ocular neovascularization. | 4.71e-06 | 2 | 76 | 2 | 20607799 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31253864 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 34465718 | ||
| Pubmed | XPB mediated retroviral cDNA degradation coincides with entry to the nucleus. | 4.71e-06 | 2 | 76 | 2 | 21167544 | |
| Pubmed | Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. | 4.71e-06 | 2 | 76 | 2 | 22185818 | |
| Pubmed | Two subunits of the canine signal peptidase complex are homologous to yeast SEC11 protein. | 4.71e-06 | 2 | 76 | 2 | 2188978 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19628708 | ||
| Pubmed | Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA. | 4.71e-06 | 2 | 76 | 2 | 15654879 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28474168 | ||
| Pubmed | Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. | 4.71e-06 | 2 | 76 | 2 | 20847146 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DDX19A SNW1 SMCHD1 SEC11A ATL3 PIP5K1A NCK1 EMD CDC25A NOMO1 KPNB1 | 8.54e-06 | 974 | 76 | 11 | 28675297 |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 35098646 | ||
| Pubmed | Annexin A2 promotes angiogenesis after ischemic stroke via annexin A2 receptor - AKT/ERK pathways. | 1.41e-05 | 3 | 76 | 2 | 36367512 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 26416603 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23792445 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 35413401 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 28694388 | ||
| Pubmed | High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2. | 1.41e-05 | 3 | 76 | 2 | 27470587 | |
| Pubmed | Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow. | 1.41e-05 | 3 | 76 | 2 | 25139998 | |
| Pubmed | Annexins--unique membrane binding proteins with diverse functions. | 1.41e-05 | 3 | 76 | 2 | 15169834 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24808179 | ||
| Pubmed | Impaired osteoblast differentiation in annexin A2- and -A5-deficient cells. | 1.41e-05 | 3 | 76 | 2 | 25222280 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 26963384 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 17466626 | ||
| Pubmed | Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes. | 1.41e-05 | 3 | 76 | 2 | 15064349 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 28334824 | ||
| Pubmed | Tenascin-c renders a proangiogenic phenotype in macrophage via annexin II. | 1.41e-05 | 3 | 76 | 2 | 28857429 | |
| Pubmed | Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B. | 1.41e-05 | 3 | 76 | 2 | 31160583 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 25620205 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 35900381 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23382212 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 22223826 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 25597631 | ||
| Pubmed | Generation of DNA single-strand displacement by compromised nucleotide excision repair. | 1.41e-05 | 3 | 76 | 2 | 22863773 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 25355205 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 8634333 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 38053379 | ||
| Pubmed | Chromosomal localization of the human genes for lipocortin I and lipocortin II. | 1.41e-05 | 3 | 76 | 2 | 2969496 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23995782 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 37690046 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 12820975 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 21108988 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 27045038 | ||
| Interaction | NCLN interactions | 5.35e-06 | 183 | 75 | 7 | int:NCLN | |
| Interaction | NR3C1 interactions | IL1RAPL1 DDX19A UBE2I LRRC37A3 SMCHD1 SEC11A FBXO42 FGD5 RAB1B HADHB ARPC5 NOMO3 FER1L6 KPNB1 | 1.23e-05 | 974 | 75 | 14 | int:NR3C1 |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 5.76e-05 | 31 | 44 | 3 | 81 | |
| GeneFamily | WD repeat domain containing|ERCC excision repair associated | 1.21e-04 | 7 | 44 | 2 | 1268 | |
| GeneFamily | WD repeat domain containing|Xeroderma pigmentosum complementation groups|Nucleotide excision repair | 1.61e-04 | 8 | 44 | 2 | 1125 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.53e-04 | 66 | 44 | 3 | 722 | |
| GeneFamily | DNA helicases | 7.69e-04 | 17 | 44 | 2 | 1167 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 1.68e-03 | 25 | 44 | 2 | 565 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.26e-03 | 40 | 44 | 2 | 321 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 4.68e-03 | 42 | 44 | 2 | 602 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 7.37e-03 | 53 | 44 | 2 | 103 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE | 7.77e-06 | 162 | 76 | 6 | M41204 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-05 | 196 | 76 | 5 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 196 | 76 | 5 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 196 | 76 | 5 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.20e-05 | 197 | 76 | 5 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.20e-05 | 197 | 76 | 5 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.20e-05 | 197 | 76 | 5 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.25e-05 | 198 | 76 | 5 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.25e-05 | 198 | 76 | 5 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.36e-05 | 200 | 76 | 5 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.36e-05 | 200 | 76 | 5 | 8f179b5768fd504af6dd6f6749a0bed7b689e77f | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.93e-05 | 111 | 76 | 4 | 4a22732094a9781867d501d9c05ba652c2f25048 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.07e-05 | 112 | 76 | 4 | cb351e57c99aaaf9ae6c7ff7e8ce5375552b1639 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.07e-05 | 112 | 76 | 4 | 999b5eeed4305e1a1385aadbaf017b64f21c1ee0 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.07e-05 | 112 | 76 | 4 | 004cd69b66c3b26b9a61f03279b48230da351574 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.07e-05 | 112 | 76 | 4 | 502e3f356f6e1c959bff0a39c98f33f863ce8265 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.15e-05 | 119 | 76 | 4 | 6425425b2e622c97b6c74c530ccbfe394d3b202d | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.27e-05 | 130 | 76 | 4 | 0a6b87635e650df431a88f2e6396abead84d901d | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 156 | 76 | 4 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 156 | 76 | 4 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 159 | 76 | 4 | 1472536eea61d4f13033efe42f128bae1614fa74 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 161 | 76 | 4 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-04 | 162 | 76 | 4 | 768a566e76923323c1f197f60bab472a8784490b | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 164 | 76 | 4 | 1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-04 | 168 | 76 | 4 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 170 | 76 | 4 | f664c7559e383b37845c123e41a3be316d869ba0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 170 | 76 | 4 | 0272eb1487c2545d4aa06f5d1cd77f823e1441e9 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O1-Trf|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.15e-04 | 68 | 76 | 3 | 31f9f6b4473970473f89b67643bb55dc332732d8 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.15e-04 | 68 | 76 | 3 | 91a500a68245a8a484a537aad2cc8b62ff4579f0 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.15e-04 | 68 | 76 | 3 | a89cc6fb62f50ea4124b1a6b0b30cd7ceb52e408 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.15e-04 | 68 | 76 | 3 | 3d148bb49246c3fac9a1e864ecc5e15b29863c52 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.23e-04 | 174 | 76 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 175 | 76 | 4 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 175 | 76 | 4 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 2.38e-04 | 177 | 76 | 4 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 2.49e-04 | 179 | 76 | 4 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-04 | 180 | 76 | 4 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-04 | 184 | 76 | 4 | 3b0389c3a5a16697de860e98ebc48ed39ede646f | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 185 | 76 | 4 | aa2c36e2cce0f0a536cd1dfc3788b6fee6f21b6b | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Slco3a1_(Slco3a1)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.87e-04 | 75 | 76 | 3 | 574ed1836f6bf5fa38a53af0a05fa4437f68f36b | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Slco3a1_(Slco3a1)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.87e-04 | 75 | 76 | 3 | 45f7861bfeb1c6371b73cf2ea527801342e534bc | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.98e-04 | 76 | 76 | 3 | efbbbf91bca35720d8ecddb076f2c9f4de25e44d | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.98e-04 | 76 | 76 | 3 | 254d18bece2676faa4bbeb8d48b1d327ab3c2215 | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.06e-04 | 189 | 76 | 4 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.12e-04 | 190 | 76 | 4 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.18e-04 | 191 | 76 | 4 | 631f95fd80dd3678b5b2ef201abf7fe646049af6 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.24e-04 | 192 | 76 | 4 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.24e-04 | 192 | 76 | 4 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-04 | 192 | 76 | 4 | 5388f3115ab285f3f3001af1d71543ed64b9e044 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-04 | 193 | 76 | 4 | ef007b736da56529ec628fc3df86a335e7ec3f18 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.37e-04 | 194 | 76 | 4 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.37e-04 | 194 | 76 | 4 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.37e-04 | 194 | 76 | 4 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.37e-04 | 194 | 76 | 4 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.37e-04 | 194 | 76 | 4 | 640ff8da7084a9486fc2752493b8d8059ecf4ab7 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.44e-04 | 195 | 76 | 4 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.44e-04 | 195 | 76 | 4 | 7ff04c45a02df01e3816f3c1d43585a93182a730 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 195 | 76 | 4 | 8493f2f60fc356af28b9c0e287d4cd8c8899c081 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.44e-04 | 195 | 76 | 4 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.44e-04 | 195 | 76 | 4 | 09605533aa5947bb2e5a6725c1ce89f79d330bf5 | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 3.44e-04 | 195 | 76 | 4 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 195 | 76 | 4 | 5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-04 | 196 | 76 | 4 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.51e-04 | 196 | 76 | 4 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.51e-04 | 196 | 76 | 4 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 3.51e-04 | 196 | 76 | 4 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-04 | 196 | 76 | 4 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.51e-04 | 196 | 76 | 4 | ff627244d7f5fd6a2ec009dae32d3509f0e2d95e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-04 | 196 | 76 | 4 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.51e-04 | 196 | 76 | 4 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-04 | 196 | 76 | 4 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.58e-04 | 197 | 76 | 4 | 032ccc91e604113da9bc34a6f9ddb1d45dea1892 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.58e-04 | 197 | 76 | 4 | d624f3a105b19f19a0dd253ce8de3ed13adc1f01 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.58e-04 | 197 | 76 | 4 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.58e-04 | 197 | 76 | 4 | 3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-04 | 197 | 76 | 4 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.64e-04 | 198 | 76 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.64e-04 | 198 | 76 | 4 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-04 | 198 | 76 | 4 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-04 | 198 | 76 | 4 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.64e-04 | 198 | 76 | 4 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 3.64e-04 | 198 | 76 | 4 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.64e-04 | 198 | 76 | 4 | 270cecff42b87b7e03f09dd9f99547b287b4598c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-04 | 198 | 76 | 4 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-04 | 198 | 76 | 4 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 3.64e-04 | 198 | 76 | 4 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.64e-04 | 198 | 76 | 4 | 8b3f4effaaccf8777cde854d5d8a765962f7312b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-04 | 199 | 76 | 4 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.71e-04 | 199 | 76 | 4 | bfc157be6e9f84739848eb19b718de5b17f3fa88 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.71e-04 | 199 | 76 | 4 | 180b3997174fd63bdf3b828063a13483eb4cab29 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.71e-04 | 199 | 76 | 4 | 5b140ac88ebc25ce397ae577e48f3e271faf46e7 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.71e-04 | 199 | 76 | 4 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.71e-04 | 199 | 76 | 4 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.71e-04 | 199 | 76 | 4 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | NS-moderate-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.71e-04 | 199 | 76 | 4 | aa2b51940115c22768c0d7493b4b60d41df3f376 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.71e-04 | 199 | 76 | 4 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-04 | 199 | 76 | 4 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | moderate-Epithelial-Secretory-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.79e-04 | 200 | 76 | 4 | 6f29ef9dcf126c5c19386f6aa9a20c38a2c8ccc8 | |
| Disease | hypertension | 1.22e-05 | 307 | 74 | 7 | EFO_0000537 | |
| Disease | Charcot-Marie-Tooth disease type 4H (implicated_via_orthology) | 3.71e-05 | 4 | 74 | 2 | DOID:0110192 (implicated_via_orthology) | |
| Disease | X-linked Aarskog syndrome (implicated_via_orthology) | 3.71e-05 | 4 | 74 | 2 | DOID:6683 (implicated_via_orthology) | |
| Disease | Photosensitive Trichothiodystrophy | 3.71e-05 | 4 | 74 | 2 | C1866504 | |
| Disease | HIV-associated neurocognitive disorder, asymptomatic neurocognitive impairment | 6.17e-05 | 5 | 74 | 2 | EFO_0007948, EFO_0007983 | |
| Disease | xeroderma pigmentosum (is_implicated_in) | 9.25e-05 | 6 | 74 | 2 | DOID:0050427 (is_implicated_in) | |
| Disease | xeroderma pigmentosum (implicated_via_orthology) | 9.25e-05 | 6 | 74 | 2 | DOID:0050427 (implicated_via_orthology) | |
| Disease | asphyxia neonatorum (biomarker_via_orthology) | 9.25e-05 | 6 | 74 | 2 | DOID:11088 (biomarker_via_orthology) | |
| Disease | Trichothiodystrophy Syndromes | 9.25e-05 | 6 | 74 | 2 | C1955934 | |
| Disease | Cockayne syndrome (implicated_via_orthology) | 9.25e-05 | 6 | 74 | 2 | DOID:2962 (implicated_via_orthology) | |
| Disease | Beta blocking agent use measurement | 1.97e-04 | 114 | 74 | 4 | EFO_0009929 | |
| Disease | Xeroderma pigmentosum | 2.21e-04 | 9 | 74 | 2 | cv:C0043346 | |
| Disease | interleukin-36 alpha measurement | 2.21e-04 | 9 | 74 | 2 | EFO_0021851 | |
| Disease | Basal cell carcinoma | 3.36e-04 | 11 | 74 | 2 | C0007117 | |
| Disease | Antihypertensive use measurement | 5.47e-04 | 265 | 74 | 5 | EFO_0009927 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 5.54e-04 | 14 | 74 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 9.69e-04 | 301 | 74 | 5 | DOID:684 (is_marker_for) | |
| Disease | Down syndrome (is_marker_for) | 1.39e-03 | 22 | 74 | 2 | DOID:14250 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | TBC1D9B ERCC3 LRRC37A CSF1R LRRC37A2 FGD5 HADHB GALNT5 ENPEP | 1.44e-03 | 1074 | 74 | 9 | C0006142 |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 1.65e-03 | 24 | 74 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | triglyceride measurement, alcohol drinking | 2.00e-03 | 99 | 74 | 3 | EFO_0004329, EFO_0004530 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.12e-03 | 101 | 74 | 3 | EFO_0004530, EFO_0007878 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 2.25e-03 | 28 | 74 | 2 | DOID:7998 (biomarker_via_orthology) | |
| Disease | Mental Retardation, X-Linked | 2.41e-03 | 29 | 74 | 2 | C1136249 | |
| Disease | diabetes mellitus (is_implicated_in) | 2.41e-03 | 29 | 74 | 2 | DOID:9351 (is_implicated_in) | |
| Disease | pappalysin‐1 measurement | 2.41e-03 | 29 | 74 | 2 | EFO_0010618 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPYQLKYGDMEESNL | 356 | P83436 | |
| YKAMKLLLLYGAELG | 256 | Q86SG2 | |
| EENKGFYYIMKELPQ | 276 | P28330 | |
| EPAAFLILLKYMYSD | 186 | Q96KE9 | |
| LNYEYLPTMGLKSFI | 66 | Q8NHS2 | |
| EYMKAINFAKGEPRY | 111 | Q8IYW2 | |
| LLMFPYGYKCTKLDD | 311 | P48052 | |
| KPLYFADRLYDSMKG | 266 | P07355 | |
| KPLYFADQLYDSMKG | 266 | A6NMY6 | |
| ALAMGYKPKAYLRDF | 326 | P55084 | |
| LMKYIYKGFESPSDN | 106 | O15511 | |
| IVPKMVYDFLYGNKS | 76 | Q8NH16 | |
| MNPEYDYLFKLLLIG | 1 | Q9H0U4 | |
| GYFMIPLYDKGDFIL | 76 | P69849 | |
| GALQFMAYELLKLKY | 196 | Q9H2D1 | |
| FGGLMDKKQNVKYYP | 691 | Q6P3S6 | |
| GYFMIPLYDKGDFIL | 76 | Q5JPE7 | |
| DPYLFKLPALKYLDM | 981 | O60309 | |
| KVRQAFLGLMPYYKD | 151 | Q96MP8 | |
| PGYAAETYLKMGDLK | 821 | Q9HBG6 | |
| DPYLFKLPALKYLDM | 981 | A6NM11 | |
| DPYLFKLPALKYLDM | 981 | A6NMS7 | |
| FIMINPLEYKYKNGA | 101 | Q8TAT5 | |
| GERLYDLNMPAYVKF | 101 | P16333 | |
| PIGYYDAQKLLEKMG | 296 | Q04609 | |
| DMLEKHYGYKLFIPD | 436 | Q9NZN1 | |
| LYEMAALQSPFYGDK | 226 | Q8TDX7 | |
| MNDVLLYTYPQKDGK | 1136 | Q6ZNL6 | |
| GYFMIPLYDKGDFIL | 76 | Q15155 | |
| MKLNVDGLLVYFPYD | 1 | P18074 | |
| DPYLFELPALKYLDM | 671 | Q96QE4 | |
| KKEEYKMALYNLYPG | 1986 | P00451 | |
| VGGAYYNLDSKLKMP | 146 | Q15040 | |
| YFAMNYSLPKLDKIA | 336 | Q07075 | |
| ILQKLAPFLKMYGEY | 236 | Q5JSP0 | |
| APFLKMYGEYVKNFD | 241 | Q5JSP0 | |
| DLLGFMLFYKEAPYQ | 526 | P06213 | |
| AEFLQKLLPGYYMNL | 201 | Q99755 | |
| QLKMFLDEYDDIPYK | 3856 | Q9P2D7 | |
| YKLVKDGYQMAQPAF | 866 | P07333 | |
| KQMIFTGPDYIKDYL | 16 | Q96LM5 | |
| DYLKDNLDKYMSQFP | 541 | Q7Z7M9 | |
| KGKSFILDFMLRYLY | 71 | Q6DD88 | |
| GEFLKYMEAFKPFLG | 641 | Q14974 | |
| FLVYFPLLNEMAKKY | 371 | O43148 | |
| ALLKDPFYMGLYQKR | 211 | P23368 | |
| GMGENKDKPYLLYFN | 76 | Q53GD3 | |
| DYEDPAFYMLKGKLQ | 141 | Q9HBE5 | |
| ADMYDLPKKEDALLY | 71 | P50402 | |
| YGAKDYRLQMPLKDD | 56 | P19447 | |
| IEQMGKFYPELKLAY | 181 | Q9NUU7 | |
| DKDFGYLILYPDMLI | 111 | P51530 | |
| LNTAKKGLIDYYLMP | 441 | Q9UNA4 | |
| LFYKGMASYLLPGQK | 296 | Q96EK7 | |
| PELYVLKGGYKEFFM | 461 | P30304 | |
| YVRLYKAEGLPKMNS | 246 | Q2WGJ9 | |
| IIMNDYPKFKYALLA | 166 | Q9BY50 | |
| PYILPFMFYNDVKKQ | 1606 | A6NHR9 | |
| LAEAYRLKYMFADAP | 486 | Q9NU19 | |
| LPSMLQDFLKEYHYK | 506 | O75159 | |
| FDMEAYLPKKNGLYL | 91 | A0PK00 | |
| QGLFFDMEAYLPKKN | 91 | Q9BXJ8 | |
| DMEAYLPKKNGLYLS | 96 | Q9BXJ8 | |
| YNKFLKNGIPYMNEE | 111 | Q8NA58 | |
| IGMDYDYALLELKKP | 241 | O95084 | |
| ILQKLAPFLKMYGEY | 456 | P98174 | |
| APFLKMYGEYVKNFD | 461 | P98174 | |
| AYFADLIMKNYFAPL | 606 | Q8N5C6 | |
| KQFGMPEGEKLVNYY | 146 | Q66K14 | |
| DLYKMDFLLFNYSAP | 321 | Q8NET6 | |
| KEKRPDLYALAMGYS | 1156 | Q8NI27 | |
| GLFKLRMLFKDDYPS | 56 | P63279 | |
| ILQMYYEQGLEKPFK | 306 | Q9Y6Q2 | |
| SPLFKYMDNDYAKLG | 256 | Q99747 | |
| VPGLDPDRKYKMNLY | 1316 | P22105 | |
| GLEPDHKYKMNLYGF | 2251 | P22105 | |
| LEPDNKYKMNLYGFH | 2361 | P22105 | |
| GLEPDHKYKMNLYGF | 2901 | P22105 | |
| MNDYPKFKYAVLFLL | 156 | P67812 | |
| SIYRPSKNLDKDMYG | 446 | Q13573 | |
| YKPLLSSIKNAYEGM | 91 | Q2TAA8 | |
| MAFSGIYKLDDGKPY | 1 | Q6P2D8 | |
| GPKEYLGMLQYKRED | 1356 | Q9NQX4 |